Incubation of (8R)-and (8S)-[1-'4C]hepoxilin A3 [where hepoxilin A3 is 8-hydroxy-11,12-epoxyeicosa-(5Z,9E,14Z)-trienoic acid] and glutathione with homogenates of rat brain hippocampus resulted in a product that was identified as the (8R) and (8S) diastereomers of 11-glutathionyl hepoxilin A3 by reversed-phase high performance liquid chromatographic comparison with the authentic standard made by total synthesis. Identity was further confirmed by cleavage of the isolated product with y-glutamyltranspeptidase to yield the corresponding cysteinylglycinyl conjugate that was identical by reversed-phase high performance liquid chromatographic analysis with the enzymic cleavage product derived from the synthetic glutathionyl conjugate. The glutathionyl and cysteinylglycinyl conjugate are referred to as hepoxilin A3-C and hepoxilin A3-D, respectively, by analogy with the established leukotriene nomenclature. Formation of hepoxilin A3-C was greatly enhanced with a concomitant decrease in formation of the epoxide hydrolase product, trioxilin A3, when the epoxide hydrolase inhibitor trichloropropene oxide was added to the incubation mixture demonstrating the presence of a dual metabolic pathway in this tissue involving hepoxilin epoxide hydrolase and glutathione S-transferase processes. Hepoxilin A3-C was tested using intracellular electrophysiological techniques on hippocampal CA1 neurons and found to be active at concentrations as low as 16 nM in causing membrane hyperpolarization, enhanced amplitude and duration of the postspike train afterhyperpolarization, a marked increase in the inhibitory postsynaptic potential, and a decrease in the spike threshold. These findings suggest that these products in the hepoxilin pathway of arachidonic acid metabolism formed by the rat brain may function as neuromodulators.
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Hepoxilins are biologically active epoxy alcohols formed from arachidonic acid by initial 12-lipoxygenation and subsequent intramolecular rearrangement of(12S)-hydroperoxyeicosatetraenoic acid (1) (2) (3) . This transformation is facilitated by the femc ion protoporphyrin subunit, which is present in hematin, hemoglobin (2, 3) , and other hemeproteins (unpublished observations). Two position-isomeric hepoxilins have been isolated, hepoxilin A3 [mixture of (8R) and (8S) diastereomers of 8-hydroxy-11,12-epoxyeicosa-(5Z,9E,14Z)-trienoic acid (hepoxilin A3)] and hepoxilin B3 (hydroxyl at C-10) (1) . Both products have been shown to enhance the release of insulin from rat pancreatic islets (4) . Hepoxilin A3 is capable of modulating synaptic neurotransmission and neuronal excitability (5) , facilitating the transport of calcium across membranes (6) , and raising cytosolic calcium concentrations in human neutrophils with intracellular acidification (7) . Hepoxilin A3 has also been shown to be formed by Aplysia neurons, on which it produces slow hyperpolarization (8) . These findings suggest a potential second messenger role for these products in the cell.
The formation of prostaglandins and the glutathionecontaining leukotrienes are catalyzed by specific isozymes of glutathione S-transferases. Thus, prostaglandins E2 and F2a appear to be formed through the reaction of the prostaglandin endoperoxide, prostaglandin H2, with isozymes containing the Ya subunit (9) , while leukotriene C4 is catalyzed by isozymes containing the Yb subunit (10, 11) . Hepoxilin A3 is metabolized to a glutathione conjugate, 8-hydroxy-(11R)-glutathionyl-(12S)-hydroxyeicosa-(5Z,9E,14Z)-trienoic acid (hepoxilin A3-C), by an affinity-purified mixture of glutathione S-transferases (12) , and enzymatic glutathione conjugation with hepoxilin A3 occurs at C-11 rather than at the allylic C-9 position (12) .
This report describes the formation of the glutathione C-11 conjugate termed hepoxilin A3-C by the rat brain and the demonstration of its biological activity on hippocampal CA1 neurons. In addition we provide evidence of the conversion of hepoxilin A3-C into another product, 8-hydroxy-(1lR)-cysteinylglycinyl-(12S)-hydroxyeicosa-(5Z,9E,14Z)-trienoic acid (hepoxilin A3-D), by reaction with y-glutamyltranspeptidase.
MATERIALS AND METHODS
Materials. [1-14C] Hepoxilin A3 was prepared as described from [1-14C] arachidonic acid (Amersham; specific activity, 59 mCi/mmol; 1 Ci = 37 GBq), using rat platelets as the source of 12-lipoxygenase and (12S)-hydroperoxyeicosatetraenoic acid, and hematin (Sigma) to effect the rearrangement of (12S)-hydroperoxyeicosatetraenoic acid to hepoxilin A3 (2) . The product was purified to radiochemical homogeneity using straight-phase high performance liquid chromatography (HPLC) and consisted of a mixture of two isomers racemic at C-8. Trichloropropene oxide (TCPO) was purchased from Sigma. Two synthetic hepoxilins A3 were formed (13) , which were termed more polar and less polar isomers, with the configuration at C-8 now assigned as 8R and 8S, respectively (E.J.C. and W.-G.S., unpublished method). Chemical coupling of each synthetic hepoxilin A3 with glutathione was effected by the following sequence: (i) reaction of 2.0 equivalents of N-trifluoroacetylglutathione trimethyl 
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ester with the methyl ester of hepoxilin A3 in 4:1 (vol/vol) methanol/triethylamine at 80'C for 24 hr under an atmosphere of argon to give a mixture of the C-li (R) thioether conjugate (a single isomer) and two (R and S) C-9 thioether conjugates in a ratio of 1:1.5, respectively; (ii) chromatographic separation of the C-11 and C-9 thioether conjugates using preparative thin layer chromatography on silica gel plates with 45:45: 10 (vol/vol) ethyl acetate/hexane/ methanol for development (Rf values 0.37 and 0.44 for the C-11 and C-9 conjugates, respectively); and (iii) saponification with 0.15 M potassium carbonate in 3:1 (vol/vol) water/ methanol at 230C for 24 hr under argon in the dark, separately for the C-11 and C-9 thioether conjugates. In this way the pure C-11 (R) thioether conjugate of glutathione and hepoxilin A3 (hepoxilin A3-C) was obtained in both 8R and 8S forms. The thioether conjugate of glutathione with hepoxilin A3 at C-9 was obtained separately as a mixture of (9R) and (9S) diastereoisomers. The determination of the structure of these conjugates was accomplished by 500 MHz 1H NMR analysis with spin decoupling using both 8-deuterated and undeuterated synthetic samples.
Brain Tissue. Male Wistar rats (200-250 g, pathogen free; Charles River Breeding Laboratories) were anaesthetized with halothane and decapitated, and the brain was dissected and placed in ice-cold oxygenated (95% 02/5% C02) artificial cerebrospinal fluid [pH 7.4, ACSF (5)]. Coronal sections of hippocampus were prepared using a Vibratome (400 Am thick) and were allowed to equilibrate at 30°C for 60 min in oxygenated ACSF. The hippocampal slices were then pooled and homogenized in 1 ml of ACSF by using a Polytron tissue homogenizer. Each experiment made use of a homogenate resulting from five hippocampal slices.
Incubations. The hippocampal homogenates were incubated with 50,000 cpm of [1-'4C]hepoxilin A3 in the presence of reduced glutathione (0, 1, and 10 mM) and in the presence of TCPO (0-3 mM). Incubations were routinely carried out at 37°C for 60 min. Incubations were terminated by the addition of 5 M formic acid (50 ,ul) , and the mixture was centrifuged quickly at 3000 rpm in a laboratory centrifuge (Hettich EBA35).
In experiments where metabolism of hepoxilin A3-C into hepoxilin A3-D was investigated, hepoxilin A3-C was first isolated by reversed-phase liquid chromatography (see below) and the purified material was treated with commercial -glutamyltranspeptidase (50 ,ug) and inhibitory postsynaptic potentials (IPSPs) was done by mono-or bipolar tungsten electrodes. Post-spike train afterhyperpolarizations (AHPs) were generated by 100-ms constant current depolarizing pulses. During drug perfusion, the pulse was adjusted if necessary to obtain the same number of spikes as required to generate the pre-drug AHP. All measurements of the AHP, postsynaptic potentials, and the input resistance (Rin) were done at the same membrane potential as the control pre-drug membrane potential, which variably required constant current injection. Measurements included the maximum amplitude of the EPSP, IPSP, and AHP from the prestimulus baseline. The duration of the AHP was measured after the offset of the 100-ms depolarizing pulse until the AHP reached the level of the prestimulus baseline. (14) (Fig. LA) . When glutathione was included in the incubation, more polar products were detected on reversed-phase HPLC whose formation was dependent on the concentration of glutathione used ( Fig. 1 B and C) . Formation of these polar products was enhanced when TCPO, the hepoxilin epoxide hydrolase inhibitor, was used (Fig. 1D) . That these more polar products were formed enzymatically was shown by their lack of formation when heat-inactivated enzyme was used (Fig. 1E) . The polar products were shown to consist of two C-8 diastereomers that migrated chromatographically with authentic standards of(8R) and (85)-hepoxilin A3-C, the 11-glutathione conjugate of hepoxilin A3 derived from reaction of glutathione S-transferase with the more polar (8R) and less polar (85) isomers ofhepoxilin A3 (Fig. 1F) (12) and compared with authentic chemically derived products. [Retention times were: hepoxilin A3-C: more polar isomer = 15.5 min; less polar isomer = 19.6 min. 9-Glutathione conjugate of hepoxilin A3: more polar isomer = 13.5, 18.0 min; less polar isomer = 3.5, 13.5 min; product derived from brain = 15.5 and 19.6 min. Solvent: methanol/water/acetic acid, 55:45:0.01 (vol/ vol). Column: ,uBondapak C18, at a flow rate of 1.5 ml/min.] Effect of TCPO on the Formation of Hepoxiln A3-C. We found that TCPO inhibits a purified preparation of hepoxilin epoxide hydrolase from rat liver (unpublished results) as well as the rat brain preparation used in this study (Fig. 1D) . Addition ofTCPO at various concentrations from 0.3 to 3 mM caused progressive inhibition of trioxilin A3 formation by the hippocampus preparation with a concomitant dose-dependent increase in formation of hepoxilin A3-C (Fig. 2) .
Formation of Hepoxilin A3-D. Brain-derived hepoxilin A3-C [mixture of (8R) and (8S) isomers] formed in the above incubations was isolated by reversed-phase HPLC and treated with y-glutamyltranspeptidase to investigate whether the biological product indeed had a conjugated glutathione. Analysis of the reaction mixture indicated the appearance of a less-polar metabolite (two isomers) as expected of a cysteinylglycinyl conjugate (hepoxilin A3-D) (Fig. 3B) . The same products were formed when glutathione S-transferaseProc. Natl. Acad. Sci. USA 87 (1990) derived hepoxilin A3-C was treated with -glutamyltranspeptidase (Fig. 3D ).
Electrophysiological Effects of Hepoxilin A3-C [(8R) form]
on Hippocampal CAl Neurons. Hepoxilin A3-C [(8R) form] caused hyperpolarization in eight out of nine hippocampal CA1 neurons that took 5-15 min to develop (Fig. 4A) . Hepoxilin A3-C caused an increase in the duration and amplitude of the AHP (Fig. 4B) . There was no appreciable effect of hepoxilin A3-C on the EPSP but both the early chloride-dependent and the later potassium-dependent phases of the IPSP were increased by hepoxilin A3-C (Fig.   4C ). All effects persisted for the duration of the perfusion, up to 30 min. Washout with ACSF for up to 30 min did not reverse any of the effects. When the membrane was depolarized to the control resting membrane potential, spontaneous spiking was often noted, which did not occur at that potential prior to drug application. At (Fig. 5) . Through the use of TCPO, an epoxide hydrolase inhibitor that also inhibits hepoxilin epoxide hydrolase, the molecular flux through the glutathione-conjugating pathway could be increased to favor the formation of hepoxiin A3-C [(8R) and (85) forms] in significant amounts. Rat brain is capable offorming hepoxilin A3 (15) . This product has also been shown to exert synaptic and neuromodulatory effects on hippocampal CAI neurons at low nanomolar concentrations with hyperpolarization of the membrane potential, augmentation of the post-spike train AHP and an increase in the amplitude of the IPSP and a decrease in the spike threshold (5) . We have also shown that glutathione S-transferase catalyzes the conjugation of hepoxilin A3 into the glutathione conjugate hepoxilin A3-C (12). The present results demonstrate the formation of hepoxilin A3-C by the rat brain and that this compound also has synaptic and neuromodulatory effects not unlike those of its precursor hepoxilin A3.
The formation of the hepoxilins infers the presence of a 12-lipoxygenase in the hippocampus, since these products are formed from 12-hydroperoxyeicosatetraenoic acid (2, 3) . Indeed, 12-hydroxyeicosatetraenoic acid has been isolated from brain tissue and formation of this product is stimulated by certain neurotransmitters (16) (17) (18) (19) (20) (21) . Brain tissue also contains a variety of other enzymes that metabolize arachidonic acid into biologically active products. Thus, 5-lipoxygenase activity has been demonstrated through the isolation of 5-hydroxyeicosatetraenoic acid and the glutathione conjugate leukotriene C4 (18), the latter being found in most brain regions but especially in the median eminence and hypothalamus. Leukotriene C4 has further been localized in nerve fibers in the external layer of the median eminence associated with luteinizing hormone releasing hormone (18) . Other metabolites of arachidonic acid have been shown to occur in mammalian brain. Although prostaglandin F2a was first shown to occur in brain more than two decades ago (22) , no specific function for this prostanoid has been proposed to date. The occurrence of prostaglandins E2 and D2 and thromboxane B2 in brain has been demonstrated (23) , and roles for prostaglandins E2 and D2 have been proposed in pyrogenaltered body temperature (24, 25) and in sleep pattern (26) , respectively. Hence, the diversity of the arachidonic acid cascade is well expressed in the mammalian central nervous system offering a variety of products that may be critically involved with synaptic transmission and neuronal function.
The formation of hepoxilin A3-C in the present study is analogous to the formation of leukotriene C4 in that both products are produced by a glutathione-conjugating system, likely a form of glutathione S-transferase (10) (11) (12) . It is interesting to note that a synthetic isomer of hepoxilin A3-C in which the glutathionyl residue is located at the 9-carbon position instead ofthe 11-carbon position as in hepoxilin A3-C is completely inactive on hippocampal CA1 neurons (n = 5 cells) within the concentration range used for hepoxilin A3-C (unpublished observations). The 9-glutathionyl analog is not formed enzymatically when either glutathione S-transferase or hippocampal homogenate is incubated with hepoxilin A3. Proc. Natl. Acad. Sci. USA 87 (1990) 
